Webinar | Cut Fermentation Cost Without Sacrificing Scale-Up
22nd May | 12 PM ET: Register Now

Biomatz

Biomatz is a biotech company developing AI-driven microbiome therapeutics using cooperative multi-strain design.​
2022
1-10
Seoul, Seoul-t’ukpyolsi, South Korea
  • Drug Discovery and Development
  • Nutraceuticals (e.g. Supplements)
  • Personalized Medicine Technologies
  • Probiotics

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

1.53M

Last Funding Amount

1.53M

Last Funding Date

28-06-2023

Startup Stage

Seed

Lead Investors

Korea Investment Partners, Daewoong Pharmaceutical, Korea Kolmar Co., Gyeongnam Venture Investment

Something missing or incorrect on this page? Help us enrich this information